| Subject: | FDA Notice: Endologix Powerlink System Delivery Catheter AND FDA Update on Vapotherm 2000i Respiratory Gas Administration Device |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 21 Dec 2005 - 10:00 am |
| Endologix Powerlink System Delivery Catheters
Audience: Vascular surgery healthcare professionals, OR managers, and hospital risk managers
On December 20, 2005, Endologix and FDA notified healthcare professionals of the voluntary product recall of selected Powerlink System delivery catheters marketed in the U.S., used to deliver minimally invasive treatment for abdominal aortic aneurysms.
Endologix initiated the recall as a result of an analysis of three recent reports of tip separation... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCES:
Policies / Forms / Additional Resources:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
